Circulation-Cardiovascular Quality and Outcomes最新文献

筛选
英文 中文
Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in China: Same, but Different.
IF 6.2 2区 医学
Circulation-Cardiovascular Quality and Outcomes Pub Date : 2025-03-18 DOI: 10.1161/CIRCOUTCOMES.125.011887
Derrick Y Tam, Harindra C Wijeysundera
{"title":"Cost-Effectiveness of Transcatheter Versus Surgical Aortic Valve Replacement in China: Same, but Different.","authors":"Derrick Y Tam, Harindra C Wijeysundera","doi":"10.1161/CIRCOUTCOMES.125.011887","DOIUrl":"https://doi.org/10.1161/CIRCOUTCOMES.125.011887","url":null,"abstract":"","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e011887"},"PeriodicalIF":6.2,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143651610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Effectiveness of Aortic Valve Replacement in Low- and Intermediate-Risk Chinese Patients With Severe Aortic Stenosis.
IF 6.2 2区 医学
Circulation-Cardiovascular Quality and Outcomes Pub Date : 2025-03-18 DOI: 10.1161/CIRCOUTCOMES.124.010858
Jin Peng, Xinglong Zheng, Minghuan Jiang, Xuelin Yao, Yue Ma, Mao Fu, Tao Ma, Xiaolong Shang, Yang Yan, Vinod H Thourani, Yu Fang
{"title":"Cost-Effectiveness of Aortic Valve Replacement in Low- and Intermediate-Risk Chinese Patients With Severe Aortic Stenosis.","authors":"Jin Peng, Xinglong Zheng, Minghuan Jiang, Xuelin Yao, Yue Ma, Mao Fu, Tao Ma, Xiaolong Shang, Yang Yan, Vinod H Thourani, Yu Fang","doi":"10.1161/CIRCOUTCOMES.124.010858","DOIUrl":"https://doi.org/10.1161/CIRCOUTCOMES.124.010858","url":null,"abstract":"<p><strong>Background: </strong>Transcatheter aortic valve replacement (TAVR) remains debated as an alternative to surgical aortic valve replacement (SAVR). We aimed to evaluate the cost-effectiveness of aortic valve replacement strategies in low- and intermediate-risk patients with severe aortic stenosis in China.</p><p><strong>Methods: </strong>A decision-analytic model combining decision tree and Markov model was developed to compare outcomes of universal SAVR, universal TAVR, and a risk-based strategy (SAVR in low-risk patients and TAVR in intermediate-risk patients) in a hypothetical cohort of 75-year-old patients with aortic stenosis within the perspective of the Chinese health care system. A meta-analysis was performed to derive the clinical inputs; the 2019 to 2021 claims data from Shaanxi Province were used for cost analysis, and quality of life was measured using EuroQoL-5D. One-way and probabilistic (10 000 Monte Carlo simulations) sensitivity analyses were conducted to examine the robustness of model results. Primary outcomes included total costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratio (ICER).</p><p><strong>Results: </strong>Universal TAVR gained the most QALYs (6.76 QALYs) with the highest costs (USD 58 949). Compared with universal SAVR, the risk-based strategy gained 0.12 additional QALYs at higher costs (USD 14 046); the ICER (117 048 USD/QALY) exceeded the willingness-to-pay threshold (37 657 USD/QALY, 3-fold gross domestic product per capita in China). The ICER of universal TAVR versus universal SAVR (80 526 USD/QALY) also exceeded the willingness-to-pay threshold. Sensitivity analysis showed that universal TAVR would be cost-effective if TAVR valve costs were <USD 21 477 (>44.23% cost reduction). Subgroup analysis showed that universal TAVR and risk-based strategy remained not cost-effective compared with universal SAVR in both low-risk (ICER of 64 414 USD/QALY) and intermediate-risk (ICER of 124 851 USD/QALY) patients. In 10 000 Monte Carlo simulations, the probabilities of being cost-effective for universal SAVR, universal TAVR, and risk-based strategy were 89.81%, 10.14%, and 0.05%, respectively.</p><p><strong>Conclusions: </strong>The risk-based strategy and universal TAVR appeared not to be cost-effective versus universal SAVR in low- and intermediate-risk patients with severe aortic stenosis in China.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e010858"},"PeriodicalIF":6.2,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143651607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Racial and Ethnic Differences in Prepregnancy Hypertension by Maternal Age.
IF 6.2 2区 医学
Circulation-Cardiovascular Quality and Outcomes Pub Date : 2025-03-12 DOI: 10.1161/CIRCOUTCOMES.124.011532
Natalie A Cameron, Stacy C Bailey, Kiarri N Kershaw, William A Grobman, Sadiya S Khan
{"title":"Racial and Ethnic Differences in Prepregnancy Hypertension by Maternal Age.","authors":"Natalie A Cameron, Stacy C Bailey, Kiarri N Kershaw, William A Grobman, Sadiya S Khan","doi":"10.1161/CIRCOUTCOMES.124.011532","DOIUrl":"https://doi.org/10.1161/CIRCOUTCOMES.124.011532","url":null,"abstract":"","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e011532"},"PeriodicalIF":6.2,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143606959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Use of WATCHMAN Device and 1-Year Mortality Using High-Dimensional Propensity Scores to Reduce Confounding.
IF 6.2 2区 医学
Circulation-Cardiovascular Quality and Outcomes Pub Date : 2025-03-03 DOI: 10.1161/CIRCOUTCOMES.124.011188
Julie Z Zhao, Mohammed Ruzieh, Fanxing Du, Yi Lian, Andrew J Foy, Robert W Platt, Mark S Segal, Janie Coulombe, Almut G Winterstein, Tianze Jiao
{"title":"Association Between Use of WATCHMAN Device and 1-Year Mortality Using High-Dimensional Propensity Scores to Reduce Confounding.","authors":"Julie Z Zhao, Mohammed Ruzieh, Fanxing Du, Yi Lian, Andrew J Foy, Robert W Platt, Mark S Segal, Janie Coulombe, Almut G Winterstein, Tianze Jiao","doi":"10.1161/CIRCOUTCOMES.124.011188","DOIUrl":"https://doi.org/10.1161/CIRCOUTCOMES.124.011188","url":null,"abstract":"<p><strong>Background: </strong>Previous observational studies showed left atrial appendage occlusions with the WATCHMAN device reduced 1-year mortality, which conflicted with evidence generated from randomized controlled trials. We proposed to use the high-dimensional propensity score (hdPS) to assist in nonactive comparator selection (prevalent user of medication) and compared 1-year mortality between patients with atrial fibrillation who received the WATCHMAN device (percutaneous left atrial appendage occlusion device [pLAAO]) and direct oral anticoagulants in 2 matched cohorts based on (1) traditional propensity score (PS) and (2) integrating traditional PS with information learned from hdPS.</p><p><strong>Methods: </strong>Patients entered the cohort once diagnosed with atrial fibrillation in the 15% of Medicare fee-for-service claims database from 2011 to 2018. Patients could enter the study cohort upon receiving WATCHMAN or at an outpatient visit with an atrial fibrillation diagnosis, respectively. We used PS matching with a 1:3 ratio for patients in pLAAO and direct oral anticoagulant groups. In cohort 2, we implemented a multistep approach with information learned from hdPS. The Cox proportional hazards model was used to estimate hazard ratios of outcomes with 95% CIs.</p><p><strong>Results: </strong>In cohort 1, we identified 1159 and 3477 patients in the pLAAO and direct oral anticoagulant groups with a mean age of 78.1 versus 77.5 years, 44.9% versus 40.8% of women, and a 1-year mortality rate of 8.02 versus 8.97/100 person-years (hazard ratio, 0.87 [95% CI, 0.69-1.09]). With the support of hdPS, in cohort 2, we excluded patients with malignant cancer and added frailty score in the PS model. We identified 953 and 2859 patients in the pLAAO and direct oral anticoagulant groups with a mean age of 78.1 versus 77.9 years, 47.2% versus 46.1% of women, and a 1-year mortality rate of 7.45 and 7.69/100 person-years (hazard ratio, 0.95 [95% CI, 0.73-1.24]).</p><p><strong>Conclusions: </strong>No association was found between pLAAO and 1-year mortality, which is consistent with existing evidence from randomized controlled trials. The hdPS approach provides an opportunity to improve nonactive comparator selection in traditional PS analysis.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e011188"},"PeriodicalIF":6.2,"publicationDate":"2025-03-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143538030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting Mortality in Patients Hospitalized With Acute Myocardial Infarction: From the National Cardiovascular Data Registry. 预测急性心肌梗死住院患者的死亡率:来自国家心血管数据登记。
IF 6.2 2区 医学
Circulation-Cardiovascular Quality and Outcomes Pub Date : 2025-03-01 Epub Date: 2025-01-13 DOI: 10.1161/CIRCOUTCOMES.124.011259
Kamil F Faridi, Yongfei Wang, Karl E Minges, Nathaniel R Smilowitz, Robert L McNamara, Michael C Kontos, Tracy Y Wang, Annie C Connors, Julie M Clary, Anwar D Osborne, Lucy Pereira, Jeptha P Curtis, Kristina Blankinship, Jarrott Mayfield, J Dawn Abbott
{"title":"Predicting Mortality in Patients Hospitalized With Acute Myocardial Infarction: From the National Cardiovascular Data Registry.","authors":"Kamil F Faridi, Yongfei Wang, Karl E Minges, Nathaniel R Smilowitz, Robert L McNamara, Michael C Kontos, Tracy Y Wang, Annie C Connors, Julie M Clary, Anwar D Osborne, Lucy Pereira, Jeptha P Curtis, Kristina Blankinship, Jarrott Mayfield, J Dawn Abbott","doi":"10.1161/CIRCOUTCOMES.124.011259","DOIUrl":"10.1161/CIRCOUTCOMES.124.011259","url":null,"abstract":"<p><strong>Background: </strong>In-hospital mortality risk prediction is an important tool for benchmarking quality and patient prognostication. Given changes in patient characteristics and treatments over time, a contemporary risk model for patients with acute myocardial infarction (MI) is needed.</p><p><strong>Methods: </strong>Data from 313 825 acute MI hospitalizations between January 2019 and December 2020 for adults aged ≥18 years at 784 sites in the National Cardiovascular Data Registry Chest Pain-MI Registry were used to develop a risk-standardized model to predict in-hospital mortality. The sample was randomly divided into 70% development (n=220 014) and 30% validation (n=93 811) samples, and 23 separate registry-based patient characteristics at presentation were considered for model inclusion using stepwise logistic regression with 1000 bootstrapped samples. A simplified risk score was also developed for individual risk stratification.</p><p><strong>Results: </strong>The mean age of the study cohort was 65.3 (SD 13.1) years, and 33.6% were women. The overall in-hospital mortality rate was 5.0% (n=15 822 deaths). The final model included 14 variables, with out-of-hospital cardiac arrest, cardiogenic shock, and ST-segment elevation MI as the strongest independent predictors of mortality. The model also included age, comorbidities (dyslipidemia, diabetes, prior percutaneous coronary intervention, cerebrovascular disease, and peripheral artery disease), heart failure on admission, heart rate, systolic blood pressure, glomerular filtration rate, and hemoglobin. The model demonstrated excellent discrimination (C-statistic, 0.868 [95% CI 0.865-0.871]) and good calibration, with similar performance across subgroups based on MI type, periods before and during the COVID-19 pandemic, and hospital volume. The simplified risk score included values from 0 to 25, with mortality risk ranging from 0.3% with a score of 0 to 1 up to 49.4% with a score >11.</p><p><strong>Conclusions: </strong>This contemporary risk model accurately predicts in-hospital mortality for patients with acute MI and can be used for risk standardization across hospitals and at the bedside for patient prognostication.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e011259"},"PeriodicalIF":6.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11919567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142972980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vasoactive Medications In Acute Heart Failure: What We Do Not Know Could Indeed Hurt Us. 急性心力衰竭中的血管活性药物:我们所不知道的可能会伤害我们。
IF 6.2 2区 医学
Circulation-Cardiovascular Quality and Outcomes Pub Date : 2025-03-01 Epub Date: 2025-01-27 DOI: 10.1161/CIRCOUTCOMES.124.011825
Deepika Potarazu, Jason N Katz
{"title":"Vasoactive Medications In Acute Heart Failure: What We Do Not Know Could Indeed Hurt Us.","authors":"Deepika Potarazu, Jason N Katz","doi":"10.1161/CIRCOUTCOMES.124.011825","DOIUrl":"10.1161/CIRCOUTCOMES.124.011825","url":null,"abstract":"","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e011825"},"PeriodicalIF":6.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143048538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Redefining the Rules of Revascularization: Lessons From ISCHEMIA for the Future of Appropriate Use Criteria.
IF 6.2 2区 医学
Circulation-Cardiovascular Quality and Outcomes Pub Date : 2025-03-01 Epub Date: 2025-02-26 DOI: 10.1161/CIRCOUTCOMES.124.011579
Christopher A Rajkumar
{"title":"Redefining the Rules of Revascularization: Lessons From ISCHEMIA for the Future of Appropriate Use Criteria.","authors":"Christopher A Rajkumar","doi":"10.1161/CIRCOUTCOMES.124.011579","DOIUrl":"10.1161/CIRCOUTCOMES.124.011579","url":null,"abstract":"","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e011579"},"PeriodicalIF":6.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143505493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To Reverse Rising Heart Failure Mortality, We Must Address Evidence Gaps.
IF 6.2 2区 医学
Circulation-Cardiovascular Quality and Outcomes Pub Date : 2025-03-01 Epub Date: 2025-03-04 DOI: 10.1161/CIRCOUTCOMES.124.011684
William Ward, Vinay Prasad
{"title":"To Reverse Rising Heart Failure Mortality, We Must Address Evidence Gaps.","authors":"William Ward, Vinay Prasad","doi":"10.1161/CIRCOUTCOMES.124.011684","DOIUrl":"10.1161/CIRCOUTCOMES.124.011684","url":null,"abstract":"","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e011684"},"PeriodicalIF":6.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143544127","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the Pain Experience and Treatment Considerations Along the Spectrum of Peripheral Artery Disease: A Scientific Statement From the American Heart Association.
IF 6.2 2区 医学
Circulation-Cardiovascular Quality and Outcomes Pub Date : 2025-03-01 Epub Date: 2025-02-10 DOI: 10.1161/HCQ.0000000000000135
Kim G Smolderen, Francisco Ujueta, Deborah Buckley Behan, Johan W S Vlaeyen, Elizabeth A Jackson, Madelon Peters, Mary Whipple, Karran Phillips, Jayer Chung, Carlos Mena-Hurtado
{"title":"Understanding the Pain Experience and Treatment Considerations Along the Spectrum of Peripheral Artery Disease: A Scientific Statement From the American Heart Association.","authors":"Kim G Smolderen, Francisco Ujueta, Deborah Buckley Behan, Johan W S Vlaeyen, Elizabeth A Jackson, Madelon Peters, Mary Whipple, Karran Phillips, Jayer Chung, Carlos Mena-Hurtado","doi":"10.1161/HCQ.0000000000000135","DOIUrl":"10.1161/HCQ.0000000000000135","url":null,"abstract":"<p><p>Peripheral artery disease (PAD) is an atherosclerotic condition that affects a growing number of individuals worldwide, with estimates exceeding 220 million. One of the central hallmarks of PAD is lower extremity pain, which may present as intermittent claudication and atypical leg pain, and, in more severe cases, ischemic rest pain, neuropathic pain, or phantom limb pain in those who underwent amputation. Although the majority of individuals with PAD may experience pain that is chronic in nature, the pathogenesis and phenomenology of pain may differ. Nociceptive, inflammatory, and neuropathic mechanisms all play a role in the generation of pain. Pain in PAD results in severe disability and can copresent with distress, sickness behaviors such as avoidance and further deconditioning, and concomitant depression, anxiety, and addiction secondary to opioid use. These factors potentially lead to chronic pain interacting with a multitude of domains of functioning, including physical, emotional, and behavioral. Whereas pain is a normal adaptive response, self-defeating behaviors and cognitions contribute to the persistence or worsening of the chronic pain experience, disability, and distress. Much remains unknown about the phenomenology of pain in PAD and its clinical subgroups and how it affects outcomes. Borrowing from other chronic pain syndromes, multimodal pain management strategies that emphasize a biopsychosocial model have generated a solid evidence base for the use of cognitive behavioral approaches to manage pain. Multimodal pain management in PAD is not the norm, but theoretical pathways and road maps for further research, assessment, and clinical implementation are presented in this scientific statement.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e000135"},"PeriodicalIF":6.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383889","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining Healthy Lifestyles as a Mediator of the Association Between Socially Determined Vulnerabilities and Incident Heart Failure. 检验健康生活方式在社会决定脆弱性和心力衰竭事件之间的中介作用。
IF 6.2 2区 医学
Circulation-Cardiovascular Quality and Outcomes Pub Date : 2025-03-01 Epub Date: 2025-01-16 DOI: 10.1161/CIRCOUTCOMES.124.011107
Nickpreet Singh, Chanel Jonas, Laura C Pinheiro, Jennifer D Lau, Jinhong Cui, Leann Long, Samprit Banerjee, Raegan W Durant, Madeline R Sterling, James M Shikany, Monika M Safford, Emily B Levitan, Parag Goyal
{"title":"Examining Healthy Lifestyles as a Mediator of the Association Between Socially Determined Vulnerabilities and Incident Heart Failure.","authors":"Nickpreet Singh, Chanel Jonas, Laura C Pinheiro, Jennifer D Lau, Jinhong Cui, Leann Long, Samprit Banerjee, Raegan W Durant, Madeline R Sterling, James M Shikany, Monika M Safford, Emily B Levitan, Parag Goyal","doi":"10.1161/CIRCOUTCOMES.124.011107","DOIUrl":"10.1161/CIRCOUTCOMES.124.011107","url":null,"abstract":"<p><strong>Background: </strong>Increased burden of socially determined vulnerabilities (SDV), which include nonmedical conditions that contribute to patient health, is associated with incident heart failure (HF). Mediators of this association have not been examined. We aimed to determine if a healthy lifestyle mediates the association between SDV and HF.</p><p><strong>Methods: </strong>We included adults aged 45 to 64 years old across the United States from the REGARDS cohort study (Reasons for Geographic and Racial Differences in Stroke) without evidence of HF at baseline. The primary exposure was a count of SDV based on the Healthy People 2030 framework. The primary outcome was incident HF. We assessed the role of a healthy behavior score (HBS range, 0-8) and its components (adherence to a Mediterranean diet, physical activity, lack of sedentary lifestyle, and smoking abstinence) as potential mediators of the association between SDV and incident HF.</p><p><strong>Results: </strong>We included 13 on 525 participants. The median HBS was 4, with 16% with low HBS (0-2), 55% with moderate HBS (3-5), and 29% with high HBS (6-8). Increasing burden of SDV was associated with a stepwise increase in incident HF (adjusted hazard ratio, 1.84 [95% CI, 1.32-2.52] for 1 SDV, 2.59 [95% CI, 1.87-3.60] for 2 SDV, and 4.20 [95% CI, 3.08-5.73] for ≥3 SDV). There was no statistically significant mediation of HBS for the association of SDV count of 1 and incident HF. HBS score mediated 10.6% of the association between SDV count of 2 and incident HF and 11.1% of the association for those with ≥3 SDV. This increased to 10.8% and 18.3%, respectively, in the complete case analysis. Regarding individual components of HBS as mediators, only avoidance of a sedentary lifestyle was statistically significant (8.6% mediation) for the association of SDV count of 2 and incident HF.</p><p><strong>Conclusions: </strong>A healthy lifestyle plays a small role in mediating the association between high SDV count and incident HF.</p>","PeriodicalId":49221,"journal":{"name":"Circulation-Cardiovascular Quality and Outcomes","volume":" ","pages":"e011107"},"PeriodicalIF":6.2,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11919557/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143014821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信